Dr. David Goukassian (USA)
Dr. David Goukassian is a Principal Investigator at Temple University School of Medicine, Center for
Translational Medicine. His most recent research focus is the field of Space Radiobiology, studying cardiovascular risks
for development of countermeasures during and after long-duration deep space missions. Dr. Goukassian has a wide-range
of expertise and experience that spans from Molecular and Cellular Biology, age-associated decline in DNA damage and
repair, as well as age-associated changes in cardiac repair and regeneration with specific emphasis on studies discerning
signaling cascades in the context of cardiovascular disease knockout and transgenic mouse models that mimic aging phenotype.
He is a Member of National Scientific Advisory Council of American Federation for Aging Research, Member/Consultant of the
Center for Integration of Medicine and Innovative Technology (CIMIT), a non-profit consortium of world-leading academic and
research institutions founded by Partners Healthcare, Massachusetts General Hospital, Brigham and Woman’s Hospital, MIT,
and Draper Laboratory.
Prof. Mariam Grigoryan (Denmark)
Prof. Mariam Grigorian works at the Copenhagen University, Faculty of Health and Medical Science where
she has continuing studies on the mechanisms of cancer metastasis with the main focus on brain metastasis and the role
of chronic inflammation in cancer progression as well as in the pathogenesis of other human non-communicable diseases.
She has published more than 80 articles in the International journals and supervised numerous master and PhD students and postdocs.
Prof. Nikolay Dokholyan (USA)
Prof. Dokholyan’s group at the Department of Biochemistry and Biophysics, University of North Carolina
at Chapel Hill focuses on understanding etiologies of human diseases, such as cystic fibrosis (CF), amyotrophic lateral
sclerosis (ALS), and pain conditions, such as hyperalgesia. They have utilized several integrated computational and
experimental strategies to understand, sense (recognize and report), and control aberrant biological molecules, and
uncover etiologies of human diseases. They have developed approaches to molecular structural modeling and dynamic
simulations, allowing study of structure and dynamics of biological molecules at time scales relevant to biological
systems. These approaches allowed them to make significant breakthroughs in understanding etiologies of CF and ALS.
Dr. Dokholyan has published 180 peer review articles and 16 book chapters. Dr. Dokholyan was named American Physical
Society Fellow in 2013. In 2014, Dr. Dokholyan was named Michael Hooker Distinguished Professor.
Dr. Hasmik Keshishyan (USA)
Dr. Hasmik Keshishian is a Senior Research Scientist working in the field of Proteomics at the Broad
Institute of MIT and Harvard, based in Cambridge, MA. Her focus over the past thirteen years at the Broad has been the
development and application of discovery proteomics and targeted mass spectrometry technologies for quantifying peptides,
proteins and post-translational modifications such as phosphorylation in biological fluids, cells and tissues. She
completed her PhD in Biochemistry from Yerevan State University and prior to joining the Broad Institute worked at
Millennium Pharmaceuticals in Cambridge, MA for ten years where she specialized in Mass Spectrometry and applied it
for characterization and quantitation of small molecules and proteins. Currently as a group leader at the Broad Institute,
she applies quantitative proteomics workflows to address biological and preclinical questions related to various disease
areas, while collaborating with different groups at the Broad as well as sister institutes and hospitals.
Dr. Hans Binder (Germany)
Dr. Binder’s group at the University of Leipzig is engaged in analysis of terabytes of high-throughput
data generated by newest generation sequencing and microarrays. His group has developed a comprehensive analysis and
visualization pipeline based on self-organizing maps (SOMs) that transforms large and heterogeneous sets of molecular
biological data into an atlas of sample-specific texture maps which can be directly compared in terms of similarities
Prof. Rouben Aroutiounian (Armenia)
Professor since 1988, Head of Department of Genetics and Cytology of Faculty of Biology of Yerevan State
University since 1990, Academician-Secretary of the Division of the Natural Sciences of NAS RA (since 2016), Member of the
Presidium of NAS RA (since 2016). Author of more than 250 scientific publications.
Dr. Arsen Arakelyan (Armenia)
Dr. A. Arakelyan has background in Biochemistry and Molecular Biology. He completed his undergraduate
and graduate studies in Armenia. In 2001-2004, he conducted his PhD research at the Institute of Molecular Biology (IMB),
studying the involvement of systemic inflammation in ischemic stroke. After his PhD research, he completed a postdoctoral
study at the Immunology Department of Palacky University Olomouc, Czech Republic. During 2007-2015, he was the Deputy
Director of the IMB, at the same time being a researcher at the Laboratory of Macromolecular Complexes, studying the
impact of genetic variations in the risk of development of ischemic stroke and schizophrenia. In 2011, Dr. Arakelyan
established the Group of Bioinformatics, and in 2014 he was appointed as the Director of the IMB. He is also the head
of the Bioinformatics Department at the Russian-Armenian University and an adjunct lecturer at American University of Armenia.